These clinical findings on CXCR5 demonstrate that the prognosis of ccRCC patients is poor, which is consistent with the in vitro results and supports the critical function of the CXCL13–CXCR5 axis in the development of ccRCC. This evidence concerns the gene CXCL13 and nonpapillary renal cell carcinoma.